Cancer Institute A national cancer institute
designated cancer center

Steven D. Chang, MD, the Robert C. and Jeannette Powell Professor

Publication Details

  • CyberKnife stereotactic radiosurgical rhizotomy for refractory trigeminal neuralgia.

    Tang CT, Chang SD, Tseng KY, Liu MY, Ju DT. J Clin Neurosci. 2011; 18 (11): 1449-53

    Stereotactic radiosurgery (SRS) has been established as an option for the treatment of trigeminal neuralgia (TN). Here, we report our experience of CyberKnife®-based (Accuray, Sunnyvale, CA, USA) stereotactic rhizotomy on medically refractory patients to determine its clinical effectiveness. Between January 2007 and December 2009, 14 selected patients underwent SRS for TN at our CyberKnife Center. Patients were evaluated for pain relief using a visual analog scale (VAS) score, time to reach pain relief (latency), duration of pain control, decrease of pain medication, occurrence of new dysesthesia, and side effects at the 3-month, 6-month, 1-year and 2-year follow-up. A literature analysis revealed that compared with other SRS systems, which can provide a high rate of pain control, CyberKnife® stereotactic rhizotomy yielded an earlier onset of pain relief in our cohort.

    PubMedID: 21924911

Stanford Medicine Resources:

Footer Links: